398 Bibliografia 1] Faraci M., Bertaina A., et al., Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology AssociationHematopoietic Stem Cell Transplantation Group. 2018; Biol Blood Marrow Transplant 25(2019)313-320. https://doi.org/10.1016/j.bbmt.2018.09.027 [2] Cesaro, L’esperienza clinica dell’uso di Defibrotide nel trattamento della malattia veno-occlusiva (VOD) epatica severa. Casi Clinici. Current Therapeutics, Springer Healthcare. 2020. [3] Wallhult E., Kenyon M., et al., Management of veno-occlusive disease: the multidisciplinary approach to care. 2016; European Journal of Haematology 98 (322–329). doi:10.1111/ejh.12840 [4] Botti S., Agreiter I., et al., Nursing role in the assessment and care of hepatic sinusoidal obstruction syndrome patients: a consensus paper by the “Gruppo Italiano Trapianto di Midollo Osseo”. Supportive Care in Cancer. 2020; 28:5125–5137 https://doi. org/10.1007/s00520-020-05353-9 [5] Corbacioglu S., Richardson Paul G., et al.,Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation. Expert review of gastroenterology & hepatology, 2017; VOL. 11, NO. 10, 885–898. DOI: 10.1080/17474124.2017.1370372 [6] Ní Chonghaile M., Wolownik K., Identification and Management Sinusoidal obstruction syndrome/veno-occlusive disease related to hematopoietic stem cell transplantation. Clinical Journal of Oncology Nursing. 2018; Volume 22, number 1. [7] Botti S., Orlando L., et al., Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group. Ecancer. 2016; 10:661 DOI: 10.3332/ecancer.2016.661 [8] Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. . Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. (2017) 53:138– 45. 10.1038/bmt.2017.161 [9] Bonifazi F., Barbato F., et al., Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 2020; Volume 11, Article 489. doi: 10.3389/fimmu.2020.00489 [10] Bohte A., Dierselhuis M. P., Imaging features of hepatic sinusoidal obstruction syndrome or veno-occlusive disease in children. Pediatric Radiology (2022) 52:122–133. https://doi. org/10.1007/s00247-021-05174-w [11] Dignan F., Wynn R., et al., BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. British Journal of Haematology. 2013; 163, 444–457. doi: 10.1111/bjh.12558 [12] Cairo M., Cooke K., et al., Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation. British Society for Haematology and John Wiley & Sons Ltd. 2020; doi: 10.1111/bjh.16557 [13] Mahadeo K., Bajwa R., et al., Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol. 2020; 7: e 61- 72. https://doi.org/10.1016/S2352-3026(19)30201-7 [14] Corbacioglu S, Kernan N., et al.,, Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes With Defibrotide Following Hematopoietic Cell Transplantation in Adult and Pediatric Patients . Biology of Blood and Marrow Transplantation. 2020; https://doi.org/10.1016/j. bbmt.2020.03.011 [15] Kernan N., Richardson P., et al., Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program. Pediatr Blood Cancer. 2018;e27269. DOI: 10.1002/pbc.27269 [16] Bajwa R., Mahadeo K., et al, Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescent, Part 1: Focus on Investigations, Prophylaxis and Specific Treatment. Biol Blood Marrow Transplant 23. 2017; 1817–1825. https://doi.org/10.1016/j.bbmt.2017.07.021 [17] Mahadeo K., McArthur J., et al., Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplant Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents: Part 2—Focus on Ascites, Fluid and Electrolytes, Renal, and Transfusion Issues. Biol Blood Marrow Transplant 23. 2017; 2023–2033. https:// doi.org/10.1016/j.bbmt.2017.08.014 [18] Ovchinsky N., Frazier W., et al., Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 3: Focus on Cardiorespiratory Dysfunction, Infections, Liver Dysfunction, and Delirium. Biol Blood Marrow Transplant 24. 2018; 207–218. https://doi.org/10.1016/j.bbmt.2017.08.035 [19] Badon P., Cesaro S., Assistenza infermieristica in pediatria. 2° edizione. 2015; 22.11, 592. [20] Badon P., Procedure infermieristiche in area pediatrica. 2° edizione. 2021; 34, 308-320; 39, 337-342.
RkJQdWJsaXNoZXIy ODUzNzk5